(2E)-1-(2,4-dichlorophenyl)-3-(5-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

Methyl 3-hydroxy-3-(4-methoxyphenyl)propanoate, 500mg

Bis(4-bromophenyl)(phenyl)phosphane, 98%, 1g

3-Chloro-2-piperidin-1-yl-phenylamine, 95.0%, 1g

3-(BOC-AMINOMETHYL)-BICYCLO[1.1.1]PENTANE-1-METHANOL, 95.0%, 100mg

(6-Morpholinopyridin-3-yl)boronic acid, 95.0%, 10g

1-Chloroisoquinolin-6-ol, 95.0%, 1g

N,N-DIoctylacetamide, 95%, 1g

4-Amino-3-fluoropyridine>98.0%(GC)(T)1g

1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13-trioxa-4-azahexadecan-16-oic acid, 98%, 5g

Glass syringe with Luer connection (glass), 3 ml, 1 piece

(3aS,4S,6R,6aR)-6-(6-Amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxylic acid, 97.0%, 250mg

Naphtho[1,2-c:5,6-c']bis([1,2,5]oxadiazole)>95.0%(HPLC)200mg